Additional information concerning Progenics and its business may be available in public announcements and filings made after this release.

(PGNX-C)
CONTACT: Amy Martini         Corporate Affairs         (914) 789-2816         amartini@progenics.com

company logo

If you liked this article you might like

Oversold Small-Cap Biotech Names

3 Biotechs to Buy This Summer

What Poker Taught Me About Investing

What Poker Taught Me About Investing

4 Small-Cap Biotech Stars